Sectoral Asset Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Sectoral Asset Management’s Portfolio EFTR Stock Details EFTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-95,305	Closed	-$1.37M	–	106
2024 Q1	$1.37M	Sell	95,305 -1	-0%	-$12	0.54%	54
2023 Q4	$1.11M	Hold	95,306	–	–	0.48%	63
2023 Q3	$1.43M	Hold	95,306	–	–	0.28%	94
2023 Q2	$1.98M	Hold	95,306	–	–	0.33%	85
2023 Q1	$840K	Hold	95,306	–	–	0.16%	98
2022 Q4	$1.02M	Hold	95,306	–	–	0.2%	97
2022 Q3	$1.36M	Hold	95,306	–	–	0.27%	82
2022 Q2	$3.38M	Sell	95,306 -4	-0%	-$242	0.68%	61
2022 Q1	$9.55M	Hold	95,310	–	–	1.7%	22
2021 Q4	$19.7M	Sell	95,310 -20,000	-17%	-$4.64M	2.97%	2
2021 Q3	$40.5M	Buy	+115,310	New	+$37.2M	3.37%	1

Other funds holding EFTR

Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Sectoral Asset Management's EFTR Position: Q2 2024 in Review

Sectoral Asset Management sold out of eFFECTOR Therapeutics, Inc. Common Stock (EFTR) in Q2 2024, closing a stake of 95,305 shares — an estimated $1.37M sold.

Sectoral Asset Management first reported a position in EFTR in Q3 2021 and held it in 11 quarters. The position peaked at $40.5M in Q3 2021. 18 funds tracked by Wall St. Rank hold EFTR as of Q2 2024.

Sectoral Asset Management reported no remaining eFFECTOR Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Sectoral Asset Management sold 95,305 eFFECTOR Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $1.37M.
Sectoral Asset Management first reported a position in eFFECTOR Therapeutics, Inc. Common Stock in Q3 2021 and held it in 11 quarters.
Sectoral Asset Management's eFFECTOR Therapeutics, Inc. Common Stock position peaked at $40.5M in Q3 2021.
18 funds tracked by Wall St. Rank held eFFECTOR Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Sectoral Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.